过敏诊断市场规模、份额、成长分析（按产品、按检测、按过敏原、按最终用户、按地区）- 产业预测 2025-2032

2023 年过敏诊断市场规模价值 48 亿美元，预计将从 2024 年的 53.3 亿美元增长到 2032 年的 122.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.0%。

由于过敏症的日益普及、诊断技术的进步以及对检测方法认识的不断提高，过敏诊断市场正在经历显着的增长。由于环境因素和生活方式的改变，花粉症、气喘和食物过敏等疾病的发生率不断上升，刺激了该行业的扩张。皮肤点刺试验和分子诊断等工具的创新将提高检测的效率和准确性。然而，市场面临监管障碍、先进技术高成本以及缺乏标准化等挑战，这可能会影响患者的可靠性和可及性。儘管存在这些障碍，但由于新的诊断方法、机器学习和人工智慧的整合以及对医疗保健基础设施的投资增加，预计市场将大幅成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

过敏诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 检测试剂套件
• 装置
• 服务
• 耗材

过敏诊断市场规模（按测试类型和复合年增长率） (2025-2032)

• 市场概览
• 体内测试
• 体外测试

过敏诊断市场规模（按过敏原和复合年增长率） (2025-2032)

• 市场概览
• 吸入性过敏原
• 食物过敏原
• 药物过敏原
• 其他过敏原

过敏诊断市场规模（按最终用户划分）及复合年增长率（2025-2032 年）

• 市场概览
• 诊断实验室
• 医院附设检查室
• 学术研究所
• 其他最终用户

过敏诊断市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（US）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Canon Inc.（Minaris Medical America, Inc.）（Japan/US）
• Eurofins Scientific（Luxembourg）
• EUROIMMUN Medizinische Labordiagnostika AG（Revvity Inc.）（Germany/US）
• bioMerieux SA（France）
• Stallergenes Greer Ltd.（UK）
• HollisterStier Allergy（US）
• Omega Diagnostics Group PLC（UK）
• R-Biopharm AG（Germany）
• HYCOR Biomedical（US）
• Lincoln Diagnostics, Inc.（US）
• HOB Biotech Group Corp., Ltd.（China）
• Romer Labs Division Holding GmbH（Austria）
• AESKU.GROUP GmbH（Germany）
• Neogen Corporation（US）
• ALK-Abello A/S（Denmark）
• Abbott Laboratories（US）
• Phadia（part of Thermo Fisher Scientific）（Sweden/US）

结论和建议

Allergy Diagnostics Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.33 billion in 2024 to USD 12.28 billion by 2032, growing at a CAGR of 11.0% during the forecast period (2025-2032).

The allergy diagnostics market is experiencing significant growth, driven by an increasing prevalence of allergies, advancements in diagnostic technologies, and heightened awareness of testing options. Conditions such as hay fever, asthma, and food allergies are rising due to environmental factors and lifestyle changes, stimulating the industry's expansion. Innovations in tools like skin prick tests and molecular diagnostics enhance testing efficiency and accuracy. However, the market faces challenges, including regulatory hurdles, high costs of advanced technologies, and a lack of standardization, which can impact reliability and accessibility for patients. Despite these obstacles, the market is set to grow substantially, fueled by emerging diagnostic methods, the integration of machine learning and AI, and increased investments in healthcare infrastructure.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergy Diagnostics Market

The rising trend of personalized medicine is significantly influencing the allergy diagnostics market. There is a growing demand for allergy testing that provides detailed insights into individual sensitivities, facilitating more tailored treatment options. Ongoing research focused on identifying specific biomarkers linked to allergies enhances the ability to develop customized therapeutic strategies. This shift towards personalized approaches not only improves patient care but also contributes to the expansion of the allergy diagnostics industry, as healthcare providers seek tools that enable them to deliver more targeted and effective treatments based on individual patient profiles.

Restraints in the Allergy Diagnostics Market

The proliferation of home testing kits and DIY methods is posing a significant challenge to the growth of the allergy diagnostics market. While these home-based allergy tests provide convenience for patients, they often lack the accuracy and reliability of laboratory diagnostics. This shift in preference may lead to a decline in demand for professional testing services, adversely impacting market expansion. Additionally, the adoption of DIY methods and home remedies could further stagnate the allergy diagnostics industry as patients opt for less reliable alternatives over professional consultation and testing, ultimately undermining the effectiveness and revenue potential of established diagnostic facilities.

Market Trends of the Allergy Diagnostics Market

The Allergy Diagnostics market is witnessing a significant trend towards the adoption of molecular diagnostic techniques, such as allergen component testing and next-generation sequencing. These advanced methodologies facilitate precise identification of allergens at a molecular level, leading to more accurate diagnostics and the development of tailored treatment plans that cater to individual patient sensitivities. As a result, healthcare providers can deliver enhanced patient outcomes, fostering a shift towards personalized medicine in allergy management. The use of established molecular methods, including ELISA, PCR, and NHS, is expected to surge, further propelling market growth and innovation in allergy diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Assay Kits
• Instruments
• Services
• Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2025-2032)

• Market Overview
• In-vivo Tests
• In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2025-2032)

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospital-Based Laboratories
• Academic Research Institutes
• Other End Users

Global Allergy Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Services, Tests, Allergen, End User)
  • US
  • Canada
• Europe (Product & Services, Tests, Allergen, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Tests, Allergen, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Tests, Allergen, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Tests, Allergen, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HollisterStier Allergy (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HYCOR Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lincoln Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOB Biotech Group Corp., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AESKU.GROUP GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phadia (part of Thermo Fisher Scientific) (Sweden/US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations